The NMO Game Changer
MAY 24, 2015
Sean Pittock, MD, of the Mayo Clinic in Rochester, Minnesota discusses how the identification of the antibodies associated with neuromyelitis optica has changed how this rare neurological condition is managed and studied.
Stay informed on the latest rare disease news and developments by
signing up for our newsletter
MOST POPULAR ARTICLES
CFTR Gene" href="/news/fda-approves-ivacaftor-for-cystic-fibrosis-in-certain-children-with-mutations-in-cftr-gene">FDA Approves Ivacaftor for Cystic Fibrosis in Certain Children with Mutations in
Ewings Sarcoma Treatment, CLR 131, Granted Rare Pediatric Disease Designation
Second International SYNGAP1 Conference
Gene Responsible for Recessive Spondylocarpotarsal Synostosis Syndrome Identified
STRATEGIC ALLIANCE PARTNERSHIP PROGRAM >
Familial Chylomicronemia Syndrome
MJH ASSOCIATES >
Specialty Pharmacy Times
Terms & Conditions
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.